Status:
UNKNOWN
Long Term Outcome of Extracorporeal Membrane Oxygenation Patients in China
Lead Sponsor:
Southeast University, China
Conditions:
Long-term Outcome
Extracorporeal Membrane Oxygenation
Eligibility:
All Genders
18+ years
Brief Summary
Outcomes and Long-term Quality-of-life of Patients requiring Extracorporeal Membrane Oxygenation are not known in china. A prospective study survey will be performed to assess the long-term outcome of...
Detailed Description
Patients admitted to ICUs and treated with extracorporeal membrane oxygenation from March 1,2015 to March 1,2019 were screened . Pre-Ecmo clinical parameters(diagnose,APACHE-II, SOFA,indications,expec...
Eligibility Criteria
Inclusion
- require extracorporeal membrane oxygenation
Exclusion
- irreversible disease
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03345758
Start Date
August 1 2017
End Date
December 30 2023
Last Update
July 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing Zhong-Da Hospital
Nanjing, Jiangsu, China, 210009